Clinical trial Recruiting at 1 site Observational Ages 18 to 75

How diaphragm strength changes during and after mechanical ventilation

Official title: Development of Diaphragm Atrophy, Dysfunction and Inhibited Cortical Control in Mechanical Ventilation

Run by RWTH Aachen University · NCT05211661 · Data updated 2026-11-12

This project will try to see how quickly the diaphragm weakens in ICU patients on mechanical ventilation and whether it recovers after they are taken off the ventilator.

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment20 (estimated)
SponsorRWTH Aachen University
Academic / other
Locations1 site (Aachen)
StatusRecruiting
StartedOctober 10, 2022
Main results expectedMay 1, 2028
Study endsJune 1, 2028
Registry record updatedSeptember 15, 2026
Trial IDNCT05211661 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults in the ICU who started invasive mechanical ventilation within the past 48 hours and are expected to remain ventilated for at least five days.

Probably not a fit

Patients likely to need only brief ventilation (<5 days), or those with BMI >40, active substance abuse, epilepsy, non‑MRI‑compatible implants, or who cannot actively participate after extubation are unlikely to benefit from joining.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational program that will follow ICU patients who start invasive mechanical ventilation to measure diaphragm function over time. Investigators will use twitch transdiaphragmatic pressure recordings as the primary physiological measure, combined with cortical stimulation and diaphragm electromyography to probe neural contributions. Measurements will be repeated during mechanical ventilation and after extubation to track decline and potential recovery. Participants are enrolled early in ventilation (within 48 hours) and are expected to remain ventilated for at least five days.

Why it matters

Potential benefit: If successful, the findings could help clinicians time weaning and design ventilation strategies to reduce diaphragm weakness and improve recovery.

How similar studies have gone: Animal and some human studies have demonstrated rapid ventilator‑induced diaphragm weakness, but few longitudinal studies have combined twitch transdiaphragmatic pressure with cortical stimulation and EMG.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Initiation of invasive mechanical ventilation in the Intensive Care Unit within 48 hours.
* Expected duration of invasive mechanical ventilation of at least 5 days.
* OR: elective bypass surgery with "planned" invasive mechanical ventilation

Exclusion Criteria:

* Body-mass-index (BMI) \>40
* Expected absence of active participation of the patient in study-related measurements after extubation
* Alcohol or drug abuse
* Non MRI compatible implant in the body
* Slipped disc
* Epilepsy
* Patients in an interdependence or with an employment contract with the principal investigator, Co-PI or his deputy.

Where it's running

  • RWTH Aachen University
    Aachen, Germany
    Recruiting

Study contacts

  • Principal investigator: Jens Spiesshoefer, MD — Department of Pneumology and Intensive Care Medicine, Faculty of Medicine, RWTH Aachen University, Pauwelsstraße 30, 52074, Aachen, Germany.
  • Study coordinator: Michael Dreher, Professor
  • Email: mdreher@ukaachen.de
  • Phone: +4924180

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.